COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma

Bone Marrow Transplant. 2020 Dec;55(12):2354-2356. doi: 10.1038/s41409-020-0972-8. Epub 2020 Jun 15.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Allografts
  • COVID-19 / diagnosis*
  • COVID-19 / etiology*
  • COVID-19 / therapy
  • COVID-19 Nucleic Acid Testing / methods*
  • COVID-19 Serological Testing
  • COVID-19 Serotherapy
  • CRISPR-Cas Systems
  • False Negative Reactions
  • Female
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Immunization, Passive
  • Immunocompromised Host
  • Leukemia, B-Cell / complications
  • Leukemia, B-Cell / immunology
  • Leukemia, B-Cell / therapy
  • Leukemia, Myeloid, Acute / complications
  • Leukemia, Myeloid, Acute / immunology
  • Leukemia, Myeloid, Acute / therapy
  • Male
  • Middle Aged
  • Pandemics
  • SARS-CoV-2